Astigmatism Management in Cataract Surgery With the AcrySof Toric Intraocular Lens

Sponsor
Maastricht University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT01075542
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (Other)
86
3
2
33
28.7
0.9

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if Toric intraocular lens implantation in cataract surgery is a more efficient and cost-effective treatment of astigmatism than Monofocal intraocular lens implantation.

Condition or Disease Intervention/Treatment Phase
  • Device: AcrySof Toric intraocular lens, model SN60TT
  • Device: AcrySof Monofocal IOL, model SN60AT
N/A

Detailed Description

A recent innovation in cataract surgery consists of the introduction of toric intraocular lenses (IOLs) that can correct corneal astigmatism. It offers the opportunity for patients with substantial astigmatism to achieve optimal distance vision without using spectacles. Good near vision may subsequently be achieved with low-cost reading glasses. The current practice of non-toric IOL implantation in astigmatic patients warrants the use of expensive bifocal or multifocal spectacles with cylinder correction to achieve good distance and near vision.

Objective: The primary objective of this study is to compare spectacle independence for distance vision following toric IOL implantation and monofocal intraocular lens (IOL) implantation. The secondary objectives are to compare uncorrected distance vision, residual refractive astigmatism, quality of vision, wavefront aberrations, contrast sensitivity, complication profile, costs of postoperative spectacles and cost-effectiveness.

Study design: Multi-centre randomised clinical trial. Study population: 160 patients with regular corneal astigmatism of at least 1.25 diopters in both eyes who require bilateral cataract surgery.

Intervention: Cataract surgery with implantation of a toric IOL (AcrySof model SN60TT) or an monofocal IOL (AcrySof model SN60AT).

Study Design

Study Type:
Interventional
Actual Enrollment :
86 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Efficacy and Cost-effectiveness of Toric Intraocular Lenses in Correcting Astigmatism in Cataract Surgery: a Randomised Clinical Trial
Study Start Date :
Feb 1, 2010
Actual Primary Completion Date :
Oct 1, 2012
Actual Study Completion Date :
Nov 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Toric intraocular lens

Bilateral Toric intraocular lens implantation in cataract surgery

Device: AcrySof Toric intraocular lens, model SN60TT
The lens is made of foldable acrylic material and is implanted in the capsular bag

Other: Monofocal intraocular lens

Bilateral Monofocal intraocular lens implantation in cataract surgery

Device: AcrySof Monofocal IOL, model SN60AT
The lens is made of foldable acrylic material and is implanted in the capsular bag

Outcome Measures

Primary Outcome Measures

  1. Spectacle independency [preop, 3 months and 6 months postop]

    Spectacle independency for distance vision

Secondary Outcome Measures

  1. Visual acuity [preop, 1 day, 1 month, 3 months and 6 months postop]

  2. Refractive astigmatism [preop, 3 months and 6 months postop]

  3. Higher-order wavefront aberrations [preop, 3 months and 6 months postop]

  4. Contrast sensitivity [preop, 3 months and 6 months postop]

  5. Costs related to intervention [preop, 3 and 6 months postop]

    Total cost-analysis, including out-of-hospital costs for patient

  6. Quality of vision [preop, 3 months, 6 months]

    Refractive-error related quality of vision

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Bilateral cataract

  • Bilateral corneal astigmatism (at least 1.25D)

  • Predicted residual astigmatism less than 0.5D

Exclusion Criteria:
  • Irregular corneal astigmatism or keratoconus

  • Fuchs endothelial dystrophy (stage 2)

  • Expected postoperative best-corrected visual acuity worse than logMAR +0.3

Contacts and Locations

Locations

Site City State Country Postal Code
1 Atrium Medical Center Heerlen, Brunssum, Kerkrade Netherlands
2 Maastricht University Medical Center Maastricht Netherlands 6229 HX
3 Rotterdam Eye Hospital Rotterdam Netherlands

Sponsors and Collaborators

  • Maastricht University Medical Center
  • ZonMw: The Netherlands Organisation for Health Research and Development

Investigators

  • Principal Investigator: Rudy Nuijts, MD, PhD, Maastricht University Medical Centre

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01075542
Other Study ID Numbers:
  • 082099
First Posted:
Feb 25, 2010
Last Update Posted:
Jan 14, 2014
Last Verified:
Jan 1, 2014
Keywords provided by Maastricht University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 14, 2014